Hemodialysis and Peritoneal Dialysis Market Size to Reach USD 189.31 Bn by 2034

Vantage Market Research releases its latest comprehensive report on the ‘Hemodialysis and Peritoneal Dialysis Market’ with a forecast period of 2025-2034. In 2023, the global hemodialysis and peritoneal dialysis market size was USD 101.8 billion, and is calculated at USD 108.32 billion in 2024. The hemodialysis and peritoneal dialysis market is projected to reach USD 189.31 billion in 2034, and register a revenue CAGR of 6.4% over the forecast period (2025-2034).

Market Overview:

The global hemodialysis and peritoneal dialysis market is expected to continue to register steadily inclining revenue growth, driven by rising prevalence of End-Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD), which are conditions further magnified by increasing rates of diabetes, hypertension, and rapidly aging global population. These health issues are driving increase in patient base requiring care and treatments, and as elderly individuals are more prone to kidney-related conditions, demand for associated and related treatments and machines and equipment is expected to gain momentum over the forecast period. Also, advancements in dialysis technology, particularly the development of portable and home-based dialysis machines, are enhancing treatment convenience and boosting adoption rates, and this trend is expected to contribute significantly to growth of the hemodialysis and peritoneal dialysis market.

Government policies supporting dialysis access, along with improved healthcare infrastructure, particularly in emerging markets, are further contributing to expanding treatment availability and access. In addition, rising awareness regarding kidney health and traction of early diagnosis are key trends encouraging patients to seek treatment earlier, and this is also positively impacting market growth. Increasing investments in research and development are driving innovations in dialysis solutions, such as biocompatible materials and less invasive treatment options, resulting in improved patient outcomes and fewer side effects.

Other key trends in the market include the rise of personalized treatment plans, growing role of telemedicine in dialysis care management, and increased reimbursement coverage. Moreover, demand for cost-effective dialysis solutions is rising as a result of high burden of CKD and ESRD in various countries and regions. Also, device and equipment manufacturers are expanding market reach through partnerships, acquisitions, or joint ventures with regional players or healthcare providers and this is enabling enhancement of distribution networks and opening easier access to new customer segments. Advancements in R&D capabilities and rising investment in new product development, particularly in biocompatible dialysis solutions and wearable dialysis technologies, are also strategies driving emerging trends in the market. 

Some Key Takeaways:

• The North America hemodialysis and peritoneal dialysis market is expected to maintain dominance in terms of revenue share over the forecast period. 
• The US accounted for majority revenue share contribution in North America, driven by high prevalence of CKD and ESRD, coupled with advanced healthcare infrastructure and favorable reimbursement policies.
• In Europe, Germany, France, and the UK are major revenue contributors, supported by well-regulated healthcare systems and government support for dialysis treatments.
• Asia Pacific hemodialysis and peritoneal dialysis market revenue growth has been increasing rapidly, with China and India being major contributors due to rising prevalence of diabetes and hypertension.
• Hemodialysis and peritoneal dialysis markets in Latin America and the Middle East & Africa are also gaining traction due to improved healthcare investments.
• The dialyzers segment is expected to account for largest revenue share among the product type segments in the hemodialysis market over the forecast period.
• Among the type of treatment segments, the prescription-based segment is expected to maintain dominance in terms of revenue share over the forecast period.
• The in-center hemodialysis segment leads in terms of revenue share among the treatment setting segments in the hemodialysis market due to high availability of structured care environments staffed with trained medical professionals. 
• The conventional hemodialysis segment is expected to dominate the usage segment in terms of revenue share over the forecast period. 
• The dialysis centers & clinics segment is projected to account for largest revenue share among the end-user segments in the hemodialysis market over the forecast period.
• The concentrates & solutions segment is expected to account for largest revenue share among the product type segments in the peritoneal dialysis market over the forecast period.
• The continuous Ambulatory Peritoneal Dialysis (CAPD) segment is expected to dominate the treatment type segments over the forecast period.
• The continuous peritoneal dialysis segment is expected to continue to account for largest revenue share among the usage segment in the peritoneal dialysis market over the forecast period.
• The homecare settings segment among the end-user segments is expected to lead in terms of revenue share over the forecast period.
• The global hemodialysis and peritoneal dialysis market is highly competitive, with a number of leading companies dominating the landscape. 
• Major companies such as Fresenius Medical Care, DaVita Inc., Baxter International, Medtronic, and Nipro Corporation lead among the companies in the market.

Company List:

• DaVita Inc.
• Baxter
• B. Braun SE
• Diaverum
• Nipro Europe Group Companies
• Nxstage Medical, Inc.
• Nikkiso Co., Ltd.
• Evoqua Water Technologies LLC
• Asahi Kasei Medical Co., Ltd.
• Rockwell Medical, Inc.
• Medtronic
• Dialifegroup
• JMS Co. Ltd.
• 3M
• Allmed Medical Care Holdings Limited

Recent Developments:

• August 13, 2024: Baxter International Inc., which is a leading player in the global medtech sector, entered into a definitive agreement with Carlyle), which is a global investment firm, for the sale of its Kidney Care segment. This segment, which will be renamed Vantive, is valued at US$ 3.8 billion, and Carlyle’s investment in Vantive is part of a partnership with Atmas Health, which is an entity formed in September 2022 by a group of executives to focus on acquiring and growing market-leading healthcare businesses. This transaction, set to close in late 2024 or early 2025 following regulatory approval, aligns with Baxter’s strategic realignment aimed at enhancing performance and creating value, and also highlights Baxter's focus on enhancing its specialized Kidney Care segment.
• August 22, 2024: Fresenius Medical Care (FME), which is a global leader in kidney care, has reached a significant milestone with over 14,000 patients in the US now utilizing its NxStage systems for Home Hemodialysis (HHD) therapy. This achievement spans both Fresenius Kidney Care clinics and other healthcare providers. Also, the company has introduced the latest version of its home dialysis machine, the NxStage Versi HD, now equipped with GuideMe Software. This new version includes several updates designed to streamline treatment, improve the learning process, and enhance the overall user experience. These advancements demonstrate the reliability and effectiveness of the NxStage system in providing safe, high-quality care to patients within the comfort of their homes. From January to April 2024, the number of new HHD patients starting treatment with NxStage in the US saw an 18% increase compared to the same period in 2023.
• August 22, 2024: A team of researchers from UNC-Chapel Hill announced a project focused on developing innovative membrane technology aimed at significantly shrinking dialysis equipment, making it more convenient and accessible for patients worldwide. The researchers are working to create highly efficient membranes that could enable a portable dialysis device, potentially as small as a smartphone. This project, named ‘Graphene Oxide Membranes for Portable Kidney Dialysis’ (GENESIS), envisions a device that would function using the body’s natural blood pressure and lightweight disposable cartridges. The long-term goal is to provide continuous dialysis, allowing patients to undergo treatment around the clock while maintaining their everyday activities and minimizing the need for regular clinic visits..

Global Hemodialysis and Peritoneal Dialysis Market Segmentation:

Hemodialysis Market Segmentation:

By Product Type:

• Hemodialysis Machines
• Dialyzers
• Bloodline Systems
• Water Treatment Systems 
• Concentrates & Solutions
• Other Accessories and Consumables 

By Treatment Setting:

• In-Center Hemodialysis
• Home Hemodialysis

By Modality:

• Conventional Hemodialysis
• Short Daily Hemodialysis
• Nocturnal Hemodialysis

By End User:

• Hospitals
• Dialysis Centers & Clinics
• Homecare Settings

Peritoneal Dialysis Market Segmentation:

By Product Type:

• Peritoneal Dialysis Machines
• Concentrates & Solutions
• Catheters & Tubes
• Other Accessories

By Treatment Type:

• Continuous Ambulatory Peritoneal Dialysis (CAPD)
• Automated Peritoneal Dialysis (APD)

By Modality:

• Continuous Peritoneal Dialysis
• Intermittent Peritoneal Dialysis

By End User:

• Hospitals
• Dialysis Centers & Clinics
• Homecare Settings

Regional Segmentation: 

North America

• United States
• Canada
• Mexico

Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Rest of Latin America 

Middle East & Africa

• Saudi Arabia
• South Africa
• United Arab Emirates
• Israel
• Rest of MEA